Inicio › Síndromes mielodisplásicos › Distrito de Columbia › Washington
Ensayos clínicos de Síndromes mielodisplásicos en Washington, DC
20 estudios para Síndromes mielodisplásicos buscan participantes en centros de Washington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ReclutandoFase 2
- Walter Reed National Military Medical Center, Bethesda · A 7 mi de distancia
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Walter Reed National Military Medical Center, Bethesda · A 7 mi de distancia
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
ReclutandoFase 1
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
ReclutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
ReclutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
CHIP/CCUS Natural History Protocol
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Natural History Study of GATA2 Deficiency and Related Disorders
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Collection of Tissue Samples for Cancer Research
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutandoFase 1/2
- Children's National Medical Center, Washington D.C.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
ReclutandoFase 2
- The Center for Cancer and Blood Disorders (CCBD) - Bethesda, Bethesda · A 7 mi de distancia
Mosaic Trial for Stem Cell Transplant Recipients
Reclutando
- Georgetown University School of Medicine, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Cancer Support Community Research & Training Institute, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ReclutandoFase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Silver Spring · A 7 mi de distancia
- Massive Bio SYNERGY-AI site, Bethesda · A 7 mi de distancia
Más información sobre Síndromes mielodisplásicos en MedlinePlus
Ensayos de Síndromes mielodisplásicos en otras ciudades
- Houston, TX43 estudios
- Baldwin Park, CA26 estudios
- New York City, NY21 estudios
- Seattle, WA21 estudios
- Tampa, FL19 estudios
- Boston, MA19 estudios
- Miami, FL17 estudios
- Durham, NC14 estudios
- Columbus, OH14 estudios
- St. Louis, MO13 estudios
- Atlanta, GA13 estudios
- Chicago, IL13 estudios
Otros estudios en Washington
- Cáncer (todos los tipos)58 estudios
- Cáncer de pulmón de células no pequeñas55 estudios
- Cáncer de seno46 estudios
- Cáncer metastásico43 estudios
- Cáncer de pulmón41 estudios
- Cáncer de próstata38 estudios
- Obesidad33 estudios
- Cáncer del colon y del recto29 estudios
- Enfermedad cardiovascular28 estudios
- Cáncer de vejiga26 estudios
- Leucemia mielógena aguda24 estudios
- Cáncer de ovario23 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.